Biblio Discovery — Demo Discovery Service

23 hasil

Menampilkan 1–20 · 0,32 detik · RSS

Jurnal

British Journal of Cancer

Scopus

ISSN 0007-0920 · Springer Nature · 23 artikel di indeks

  1. Artikel Jurnal Teks lengkap

    Tumour-infiltrating lymphocytes: from prognosis to treatment selection

    Koen Brummel; Anneke L. Eerkens; Marco de Bruyn dkk.

    British Journal of Cancer · 2022 · Inggris · OpenAlex Scopus

    Tumour-infiltrating lymphocytes (TILs) are considered crucial in anti-tumour immunity. Accordingly, the presence of TILs contains prognostic and predictive value. In 2011, we performed a systematic review and meta-analysis on the prognostic value of TILs across cancer types. Since then, the advent…

  2. Artikel Jurnal Teks lengkap

    Achieving clinical success with BET inhibitors as anti-cancer agents

    Tatiana Shorstova; William David Foulkes; Michael Witcher

    British Journal of Cancer · 2021 · Inggris · OpenAlex Scopus

    The transcriptional upregulation of oncogenes is a driving force behind the progression of many tumours. However, until a decade ago, the concept of 'switching off' these oncogenic pathways represented a formidable challenge. Research has revealed that members of the bromo- and extra-terminal…

  3. Artikel Jurnal Teks lengkap

    Artificial intelligence in oncology: current applications and future perspectives

    Claudio Luchini; Antonio Pea; Aldo Scarpa

    British Journal of Cancer · 2021 · Inggris · OpenAlex Scopus

    Artificial intelligence (AI) is concretely reshaping the landscape and horizons of oncology, opening new important opportunities for improving the management of cancer patients. Analysing the AI-based devices that have already obtained the official approval by the Federal Drug Administration (FDA)…

  4. Artikel Jurnal Teks lengkap

    Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression

    Fabiana Lüönd; Stefanie Tiede; Gerhard Christofori

    British Journal of Cancer · 2021 · Inggris · OpenAlex Scopus

    Heterogeneity within a tumour increases its ability to adapt to constantly changing constraints, but adversely affects a patient's prognosis, therapy response and clinical outcome. Intratumoural heterogeneity results from a combination of extrinsic factors from the tumour microenvironment and…

  5. Artikel Jurnal Teks lengkap

    Promises and challenges of adoptive T-cell therapies for solid tumours

    Matteo Morotti; Ashwag Albukhari; Abdulkhaliq Alsaadi dkk.

    British Journal of Cancer · 2021 · Inggris · OpenAlex Scopus

    Cancer is a leading cause of death worldwide and, despite new targeted therapies and immunotherapies, many patients with advanced-stage- or high-risk cancers still die, owing to metastatic disease. Adoptive T-cell therapy, involving the autologous or allogeneic transplant of tumour-infiltrating…

  6. Artikel Jurnal Teks lengkap

    Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance

    Melanie A. Krook; Julie W. Reeser; Gabrielle Ernst dkk.

    British Journal of Cancer · 2020 · Inggris · OpenAlex Scopus

    Fibroblast growth factor receptors (FGFRs) are aberrantly activated through single-nucleotide variants, gene fusions and copy number amplifications in 5-10% of all human cancers, although this frequency increases to 10-30% in urothelial carcinoma and intrahepatic cholangiocarcinoma. We begin this…

  7. Artikel Jurnal Teks lengkap

    Insights into the role of sialylation in cancer progression and metastasis

    Christopher Dobie; Danielle Skropeta

    British Journal of Cancer · 2020 · Inggris · OpenAlex Scopus

    Upregulation of sialyltransferases-the enzymes responsible for the addition of sialic acid to growing glycoconjugate chains-and the resultant hypersialylation of up to 40-60% of tumour cell surfaces are established hallmarks of several cancers, including lung, breast, ovarian, pancreatic and…

  8. Artikel Jurnal Teks lengkap

    Cancer as a disease of old age: changing mutational and microenvironmental landscapes

    Ezio Laconi; Fabio Marongiu; James V. DeGregori

    British Journal of Cancer · 2020 · Inggris · OpenAlex Scopus

    Why do we get cancer mostly when we are old? According to current paradigms, the answer is simple: mutations accumulate in our tissues throughout life, and some of these mutations contribute to cancers. Although mutations are necessary for cancer development, a number of studies shed light on roles…

  9. Artikel Jurnal Teks lengkap

    EMTome: a resource for pan-cancer analysis of epithelial-mesenchymal transition genes and signatures

    Suhas V. Vasaikar; Abhijeet P. Deshmukh; Petra den Hollander dkk.

    British Journal of Cancer · 2020 · Inggris · OpenAlex Scopus

    BACKGROUND: The epithelial-mesenchymal transition (EMT) enables dissociation of tumour cells from the primary tumour mass, invasion through the extracellular matrix, intravasation into blood vessels and colonisation of distant organs. Cells that revert to the epithelial state via the…

  10. Artikel Jurnal Teks lengkap

    Trends in cervical cancer incidence in sub-Saharan Africa

    Elima Enaji Jedy-Agba; Walburga Yvonne Joko-Fru; Biying Liu dkk.

    British Journal of Cancer · 2020 · Inggris · OpenAlex Scopus

    BACKGROUND: Cervical cancer is the second most common cancer and the leading cause of cancer death in women in sub-Saharan Africa (SSA). METHODS: Trends in the incidence of cervical cancer are examined for a period of 10-25 years in 10 population-based cancer registries across eight SSA countries…

  11. Artikel Jurnal Teks lengkap

    Cysteine metabolic circuitries: druggable targets in cancer

    Vasco D. B. Bonifácio; Sofia Azeredo Pereira; Jacinta Serpa dkk.

    British Journal of Cancer · 2020 · Inggris · OpenAlex Scopus

    Abstract To enable survival in adverse conditions, cancer cells undergo global metabolic adaptations. The amino acid cysteine actively contributes to cancer metabolic remodelling on three different levels: first, in its free form, in redox control, as a component of the antioxidant glutathione or…

  12. Artikel Jurnal Teks lengkap

    The untapped potential of ascites in ovarian cancer research and treatment

    Caroline Elizabeth Ford; Bonnita Werner; Neville F. Hacker dkk.

    British Journal of Cancer · 2020 · Inggris · OpenAlex Scopus

    The build-up of fluid in the peritoneal cavity-ascites-is a hallmark of ovarian cancer, the most lethal of all gynaecological malignancies. This remarkable fluid, which contains a variety of cellular and acellular components, is known to contribute to patient morbidity and mortality by facilitating…

  13. Artikel Jurnal Teks lengkap

    Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond

    Laura H. Keller; Yassine Belloum; Harriet Wikman dkk.

    British Journal of Cancer · 2020 · Inggris · OpenAlex Scopus

    Cell-free DNA (cfDNA) derived from tumours is present in the plasma of cancer patients. The majority of currently available studies on the use of this circulating tumour DNA (ctDNA) deal with the detection of mutations. The analysis of cfDNA is often discussed in the context of the noninvasive…

  14. Artikel Jurnal Teks lengkap

    The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials

    Giovanni Fucà; Vincenzo Guarini; Carlotta Antoniotti dkk.

    British Journal of Cancer · 2020 · Inggris · OpenAlex Scopus

    BACKGROUND: Immune-inflammatory biomarkers (IIBs) showed a prognostic relevance in patients with metastatic CRC (mCRC). We aimed at evaluating the prognostic power of a new comprehensive biomarker, the Pan-Immune-Inflammation Value (PIV), in patients with mCRC receiving first-line therapy. METHODS…

  15. Artikel Jurnal Teks lengkap

    Tumour treating fields therapy for glioblastoma: current advances and future directions

    Ola Rominiyi; Aurelie Vanderlinden; Susan Jane Clenton dkk.

    British Journal of Cancer · 2020 · Inggris · OpenAlex Scopus

    Glioblastoma multiforme (GBM) is the most common primary brain tumour in adults and continues to portend poor survival, despite multimodal treatment using surgery and chemoradiotherapy. The addition of tumour-treating fields (TTFields)-an approach in which alternating electrical fields exert…

  16. Artikel Jurnal Teks lengkap

    Mutational drivers of cancer cell migration and invasion

    Nikita M. Novikov; Sofia Y. Zolotaryova; Alexis M. Gautreau dkk.

    British Journal of Cancer · 2020 · Inggris · OpenAlex Scopus

    Genomic instability and mutations underlie the hallmarks of cancer-genetic alterations determine cancer cell fate by affecting cell proliferation, apoptosis and immune response, and increasing data show that mutations are involved in metastasis, a crucial event in cancer progression and a…

  17. Artikel Jurnal Teks lengkap

    Cytotoxic CD8+ T cells in cancer and cancer immunotherapy

    Hans Raskov; Adile Orhan; Jan Pravsgaard Christensen dkk.

    British Journal of Cancer · 2020 · Inggris · OpenAlex Scopus

    Abstract The functions of, and interactions between, the innate and adaptive immune systems are vital for anticancer immunity. Cytotoxic T cells expressing cell-surface CD8 are the most powerful effectors in the anticancer immune response and form the backbone of current successful cancer…

  18. Artikel Jurnal Teks lengkap

    Cancer health disparities in racial/ethnic minorities in the United States

    Valentina A. Zavala; Paige M. Bracci; John M. Carethers dkk.

    British Journal of Cancer · 2020 · Inggris · OpenAlex Scopus

    There are well-established disparities in cancer incidence and outcomes by race/ethnicity that result from the interplay between structural, socioeconomic, socio-environmental, behavioural and biological factors. However, large research studies designed to investigate factors contributing to cancer…

  19. Artikel Jurnal Teks lengkap

    Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours

    David S. Hong; Yoon‐Koo Kang; Mitesh J. Borad dkk.

    British Journal of Cancer · 2020 · Inggris · OpenAlex Scopus

    BACKGROUND: In this first-in-human, Phase 1 study of a microRNA-based cancer therapy, the recommended Phase 2 dose (RP2D) of MRX34, a liposomal mimic of microRNA-34a (miR-34a), was determined and evaluated in patients with advanced solid tumours. METHODS: Adults with various solid tumours…

  20. Artikel Jurnal Teks lengkap

    IDH mutation in glioma: molecular mechanisms and potential therapeutic targets

    Sue Han; Yang Liu; Sabrina J. Cai dkk.

    British Journal of Cancer · 2020 · Inggris · OpenAlex Scopus

    Isocitrate dehydrogenase (IDH) enzymes catalyse the oxidative decarboxylation of isocitrate and therefore play key roles in the Krebs cycle and cellular homoeostasis. Major advances in cancer genetics over the past decade have revealed that the genes encoding IDHs are frequently mutated in a…